Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -159.32% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 7.86% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 14.74% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 57.67% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -44.49% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -27.15% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 2.29% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 3.59% |
| 10 | Medpace Holdings | 13.30 Bn | 12.64 Bn | 196.33 Mn | 8.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.09% |
| Dec 31, 2025 | 15.48% |
| Sep 30, 2025 | 15.25% |
| Jun 30, 2025 | 2.16% |
| Mar 31, 2025 | 11.70% |
| Dec 31, 2024 | 49.45% |
| Sep 30, 2024 | 36.68% |
| Jun 30, 2024 | 44.68% |
| Mar 31, 2024 | 40.74% |
| Dec 31, 2023 | 14.02% |
| Sep 30, 2023 | 6.85% |
| Jun 30, 2023 | 23.72% |
| Mar 31, 2023 | 18.89% |
| Dec 31, 2022 | 37.25% |
| Sep 30, 2022 | 35.93% |
| Jun 30, 2022 | 23.60% |
| Mar 31, 2022 | 41.58% |
| Dec 31, 2021 | -1.64% |
| Sep 30, 2021 | 17.16% |
| Jun 30, 2021 | 65.67% |